IL3.F Integra LifeSciences Holdings Corporation

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
12.80 EUR
Close of Nov 13, 2026
7.60 17.30
Market cap
EUR 995M
P/E
85.3x
P/B
0.46x
ROE
0.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is IL3.F undervalued?

Graham number
Price12.80
Graham value9.72
Premium31.7%

IL3.F trades 31.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Integra LifeSciences Holdings Corporation fundamental analysis

No fundamental analysis for Integra LifeSciences Holdings Corporation yet.

Integra LifeSciences Holdings Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitori…

Full company profile